The only technical publication devoted exclusively to readers involved in development and production of orally inhaled and nasal drug products (OINDPs).


Spray drying to enable new inhaled drug products

Exploring the robustness of the pharmacopeial methods for testing dry powder inhalers (DPIs); Part 1: Delivered dose uniformity (DDU)

Back Page:

Research focus on nasal biopharmaceutics: A workshop by the Biopharmaceutics Focus Group of the APS

Cross-Industry Organizations:

An update from the Product Quality Research Institute (PQRI)

Application of biological models to inform research and development of inhalation products

Excipient enhanced growth (EEG): Expanding delivery options for the treatment of lung diseases

Back Pages:

Nestlé reconsidering only FDA-approved peanut allergy drug for children due to slow uptake

Food allergy bravery clinic helps children overcome anxiety

From the Archive:

Examining the influence of carrier lactose on the performance of dry powder inhaler (DPI) formulations: A case study


Industry Organizations

Inhalation 1-2-3

Reference & Buyer’s Resource

Editorial Advisory Board




White Papers